Addus HomeCare (NASDAQ:ADUS) Lowered to “Buy” at StockNews.com

Addus HomeCare (NASDAQ:ADUSGet Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report released on Sunday.

Other equities research analysts have also issued reports about the company. Stephens lifted their price target on Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a research report on Friday, May 31st. Macquarie assumed coverage on Addus HomeCare in a research report on Friday, June 28th. They set an “outperform” rating and a $136.00 price target on the stock. Barclays downgraded Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 target price on the stock. in a report on Tuesday, April 23rd. Bank of America boosted their target price on Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, May 7th. Finally, Oppenheimer boosted their target price on Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a report on Friday, June 7th. One research analyst has rated the stock with a sell rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $116.25.

Get Our Latest Stock Analysis on ADUS

Addus HomeCare Price Performance

Shares of Addus HomeCare stock opened at $117.73 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.35 and a quick ratio of 1.35. The business’s 50 day simple moving average is $112.01 and its two-hundred day simple moving average is $100.71. The stock has a market capitalization of $2.13 billion, a P/E ratio of 29.21, a price-to-earnings-growth ratio of 2.27 and a beta of 1.01. Addus HomeCare has a one year low of $78.35 and a one year high of $120.53.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its quarterly earnings results on Monday, May 6th. The company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. The business had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The business’s quarterly revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.84 EPS. Analysts forecast that Addus HomeCare will post 4.36 EPS for the current year.

Insider Transactions at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 217 shares of the company’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,186,500.21. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

Hedge funds have recently bought and sold shares of the company. Principal Securities Inc. purchased a new stake in Addus HomeCare during the fourth quarter valued at $26,000. GAMMA Investing LLC bought a new stake in Addus HomeCare during the fourth quarter valued at about $34,000. EntryPoint Capital LLC bought a new stake in Addus HomeCare during the first quarter valued at about $44,000. Assetmark Inc. grew its holdings in Addus HomeCare by 33.3% during the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock valued at $165,000 after purchasing an additional 443 shares during the period. Finally, Envestnet Portfolio Solutions Inc. bought a new stake in Addus HomeCare during the fourth quarter valued at about $214,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.